KCT0002769尚未招募未知
A Multi-center, Randomized, Open label, Comparison, Pivotal Clinical Trial to Evaluate the Safety and Efficacy of Porcine Rib Cartilage for Rhinoplasty
Hans Biomed Corporation0 个研究点目标入组 74 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 74
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1. Persons over the age of 19
- •2. After hearing explanation and fully understood the details of the clinical trial, Persons who have voluntarily decided to participate in the clinical trial, thereafter have signed the consent form by themselves or legal representatives.
- •3. Persons who heard full explanation about the procedures, effects and side effects of anesthesia, surgical procedures, and screening related to this trial and have signed the consent form provided by the relevant institution.
- •4. Persons who want rhinoplasty for the restoration of the nose deformed due to cosmetic procedure
- •surgery, congenital/acquired deformity or aging.
- •5. Persons who showed normal blood coagulation, renal function and liver function during screening
- •6. Persons who did not undergo surgery on the corresponding site within 1 year before screening and recovered from the side effects of the treatment in the past.
排除标准
- •1. Other than this investigational medical device, Persons who have history of injecting an autogenous fat, an autogenous dermal fat, and other foreign materials at the surgical site. Or persons who are scheduled to be fitted with another device.
- •2. Persons who have infection, contamination, or severe scar contraction at the surgical site.
- •3. Persons who have severe nose-related diseases such as rhinitis, sinusitis and nasal concha hypertrophy, etc.
- •4. Persons who have hepatic dysfunction or blood clotting disorders or shall be treated with anticoagulants (Heparin, Warfarin) or aspirin (low dose aspirin 100 mg, up to 300 mg / day) during this clinical period.
- •5. Persons who have medical history of hypertrophic scarring or keloids.
- •6. Persons who have malignant atopic dermatitis.
- •7. Persons who have medical history of anaphylactic or severe allergy symptoms, or showed hypersensitivity to pig-derived materials in the past.
- •8. Persons who showed hypersensitivity to lidocaine or amide-based topical anesthetics in the past.
- •9. When screening, Persons who have ongoing or uncontrolled infectious diseases or persons who have immune-related diseases that can interfere with wound healing, or persons who expected to be treated or will be treated with immunosuppressants or corticosteroids during the clinical trial period.
- •10. When screening, Persons who showed clinically serious disorders in ENT system, cardiovascular system, digestive system, respiratory system, endocrine system, central nervous system, circulatory system and musculoskeletal system and immune system, or persons who have mental diseases which may have effect on this clinical trial.
- •11. When screening, Women who are pregnant or breast-feeding, or women who are planning for pregnancy during the clinical trial, or women who have a possibility of pregnancy but do not use medically accepted methods of contraception.
- •* Medically acceptable contraceptive methods: Condoms, oral contraception for at least 3 months, use of contraceptive for injection or insertion, intrauterine contraceptive device.
- •12. Persons who participated in other clinical trials within one month before screening.
- •13. Other than above, Persons who considered to be unsuitable for this clinical trial as judged by medical opinion and clinical opinion from the (principal) investigator.
研究者
相似试验
招募中
3 期
Efficacy and safety study to assess between three drugs (Inhaler) in patients with Chronic Obstructive Pulmonary DiseaseCTRI/2023/01/048668upin Limited
已完成
2 期
Clinical study on Yesaka Liquid in diabetic patientsCTRI/2019/05/019452Simandhar Herbal Pvt Ltd
进行中（未招募）
不适用
A comparative, randomized, open label, multicenter study on the efficacy and safety of switch treatment with aripiprazole in schizophrenic out-patient who are experiencing insufficient efficacy with risperidone and/or safety and tolerability issues, while on risperidone.MedDRA version: 9.1Level: HLGTClassification code 10039628Term: Schizophrenia and other psychotic disordersSchizophreniaEUCTR2005-000472-40-ITBRISTOL-M.SQUIBB400
已完成
2 期
A multicenter, open label, comparative study to evaluate the immunogenicity and reactogenicity of a new fully liquid pentavalent DTwP-Hib-IPV vaccine (EasyfourPolTM, Panacea Biotec Ltd.)in Healthy Infants.CTRI/2010/091/000498PANACEA BIOTEC LIMITED622
进行中（未招募）
不适用
A Comparative, Randomized, Open-label, Multicenter Study, of Directly Observed Treatment of Chronic Hepatitis C (DOT) and auto administrated treatment with Copegus® (Ro 20-9963) and Pegasys® (Ro 25-8310). - ribadotChronic Hepatitis CClassification code 10008912EUCTR2005-005650-41-ESSESP